1 Study Coverage
    1.1 OX40 Receptor Agonist Product Introduction
    1.2 Market by Type
        1.2.1 Global OX40 Receptor Agonist Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Fully Human IgG2 Agonist Ab
        1.2.3 Humanised IgG1 Agonist mAb
        1.2.4 Fully Human IgG1 Agonist mAb
    1.3 Market by Application
        1.3.1 Global OX40 Receptor Agonist Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancers
        1.3.3 Myasthenia Gravis
        1.3.4 Psoriasis
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global OX40 Receptor Agonist Sales Estimates and Forecasts 2017-2028
    2.2 Global OX40 Receptor Agonist Revenue Estimates and Forecasts 2017-2028
    2.3 Global OX40 Receptor Agonist Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global OX40 Receptor Agonist Sales by Region
        2.4.1 Global OX40 Receptor Agonist Sales by Region (2017-2022)
        2.4.2 Global Sales OX40 Receptor Agonist by Region (2023-2028)
    2.5 Global OX40 Receptor Agonist Revenue by Region
        2.5.1 Global OX40 Receptor Agonist Revenue by Region (2017-2022)
        2.5.2 Global OX40 Receptor Agonist Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global OX40 Receptor Agonist Sales by Manufacturers
        3.1.1 Global Top OX40 Receptor Agonist Manufacturers by Sales (2017-2022)
        3.1.2 Global OX40 Receptor Agonist Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of OX40 Receptor Agonist in 2021
    3.2 Global OX40 Receptor Agonist Revenue by Manufacturers
        3.2.1 Global OX40 Receptor Agonist Revenue by Manufacturers (2017-2022)
        3.2.2 Global OX40 Receptor Agonist Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by OX40 Receptor Agonist Revenue in 2021
    3.3 Global OX40 Receptor Agonist Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global OX40 Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global OX40 Receptor Agonist Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global OX40 Receptor Agonist Sales by Type
        4.1.1 Global OX40 Receptor Agonist Historical Sales by Type (2017-2022)
        4.1.2 Global OX40 Receptor Agonist Forecasted Sales by Type (2023-2028)
        4.1.3 Global OX40 Receptor Agonist Sales Market Share by Type (2017-2028)
    4.2 Global OX40 Receptor Agonist Revenue by Type
        4.2.1 Global OX40 Receptor Agonist Historical Revenue by Type (2017-2022)
        4.2.2 Global OX40 Receptor Agonist Forecasted Revenue by Type (2023-2028)
        4.2.3 Global OX40 Receptor Agonist Revenue Market Share by Type (2017-2028)
    4.3 Global OX40 Receptor Agonist Price by Type
        4.3.1 Global OX40 Receptor Agonist Price by Type (2017-2022)
        4.3.2 Global OX40 Receptor Agonist Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global OX40 Receptor Agonist Sales by Application
        5.1.1 Global OX40 Receptor Agonist Historical Sales by Application (2017-2022)
        5.1.2 Global OX40 Receptor Agonist Forecasted Sales by Application (2023-2028)
        5.1.3 Global OX40 Receptor Agonist Sales Market Share by Application (2017-2028)
    5.2 Global OX40 Receptor Agonist Revenue by Application
        5.2.1 Global OX40 Receptor Agonist Historical Revenue by Application (2017-2022)
        5.2.2 Global OX40 Receptor Agonist Forecasted Revenue by Application (2023-2028)
        5.2.3 Global OX40 Receptor Agonist Revenue Market Share by Application (2017-2028)
    5.3 Global OX40 Receptor Agonist Price by Application
        5.3.1 Global OX40 Receptor Agonist Price by Application (2017-2022)
        5.3.2 Global OX40 Receptor Agonist Price Forecast by Application (2023-2028)
6 North America
    6.1 North America OX40 Receptor Agonist Market Size by Type
        6.1.1 North America OX40 Receptor Agonist Sales by Type (2017-2028)
        6.1.2 North America OX40 Receptor Agonist Revenue by Type (2017-2028)
    6.2 North America OX40 Receptor Agonist Market Size by Application
        6.2.1 North America OX40 Receptor Agonist Sales by Application (2017-2028)
        6.2.2 North America OX40 Receptor Agonist Revenue by Application (2017-2028)
    6.3 North America OX40 Receptor Agonist Market Size by Country
        6.3.1 North America OX40 Receptor Agonist Sales by Country (2017-2028)
        6.3.2 North America OX40 Receptor Agonist Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe OX40 Receptor Agonist Market Size by Type
        7.1.1 Europe OX40 Receptor Agonist Sales by Type (2017-2028)
        7.1.2 Europe OX40 Receptor Agonist Revenue by Type (2017-2028)
    7.2 Europe OX40 Receptor Agonist Market Size by Application
        7.2.1 Europe OX40 Receptor Agonist Sales by Application (2017-2028)
        7.2.2 Europe OX40 Receptor Agonist Revenue by Application (2017-2028)
    7.3 Europe OX40 Receptor Agonist Market Size by Country
        7.3.1 Europe OX40 Receptor Agonist Sales by Country (2017-2028)
        7.3.2 Europe OX40 Receptor Agonist Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific OX40 Receptor Agonist Market Size by Type
        8.1.1 Asia Pacific OX40 Receptor Agonist Sales by Type (2017-2028)
        8.1.2 Asia Pacific OX40 Receptor Agonist Revenue by Type (2017-2028)
    8.2 Asia Pacific OX40 Receptor Agonist Market Size by Application
        8.2.1 Asia Pacific OX40 Receptor Agonist Sales by Application (2017-2028)
        8.2.2 Asia Pacific OX40 Receptor Agonist Revenue by Application (2017-2028)
    8.3 Asia Pacific OX40 Receptor Agonist Market Size by Region
        8.3.1 Asia Pacific OX40 Receptor Agonist Sales by Region (2017-2028)
        8.3.2 Asia Pacific OX40 Receptor Agonist Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America OX40 Receptor Agonist Market Size by Type
        9.1.1 Latin America OX40 Receptor Agonist Sales by Type (2017-2028)
        9.1.2 Latin America OX40 Receptor Agonist Revenue by Type (2017-2028)
    9.2 Latin America OX40 Receptor Agonist Market Size by Application
        9.2.1 Latin America OX40 Receptor Agonist Sales by Application (2017-2028)
        9.2.2 Latin America OX40 Receptor Agonist Revenue by Application (2017-2028)
    9.3 Latin America OX40 Receptor Agonist Market Size by Country
        9.3.1 Latin America OX40 Receptor Agonist Sales by Country (2017-2028)
        9.3.2 Latin America OX40 Receptor Agonist Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa OX40 Receptor Agonist Market Size by Type
        10.1.1 Middle East and Africa OX40 Receptor Agonist Sales by Type (2017-2028)
        10.1.2 Middle East and Africa OX40 Receptor Agonist Revenue by Type (2017-2028)
    10.2 Middle East and Africa OX40 Receptor Agonist Market Size by Application
        10.2.1 Middle East and Africa OX40 Receptor Agonist Sales by Application (2017-2028)
        10.2.2 Middle East and Africa OX40 Receptor Agonist Revenue by Application (2017-2028)
    10.3 Middle East and Africa OX40 Receptor Agonist Market Size by Country
        10.3.1 Middle East and Africa OX40 Receptor Agonist Sales by Country (2017-2028)
        10.3.2 Middle East and Africa OX40 Receptor Agonist Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merk
        11.1.1 Merk Corporation Information
        11.1.2 Merk Overview
        11.1.3 Merk OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merk OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merk Recent Developments
    11.2 Pfizer
        11.2.1 Pfizer Corporation Information
        11.2.2 Pfizer Overview
        11.2.3 Pfizer OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Pfizer OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Pfizer Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Corporation Information
        11.3.2 GlaxoSmithKline Overview
        11.3.3 GlaxoSmithKline OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 GlaxoSmithKline OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 GlaxoSmithKline Recent Developments
    11.4 Glenmark
        11.4.1 Glenmark Corporation Information
        11.4.2 Glenmark Overview
        11.4.3 Glenmark OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Glenmark OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Glenmark Recent Developments
    11.5 AstraZeneca (MedImmune)
        11.5.1 AstraZeneca (MedImmune) Corporation Information
        11.5.2 AstraZeneca (MedImmune) Overview
        11.5.3 AstraZeneca (MedImmune) OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 AstraZeneca (MedImmune) OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 AstraZeneca (MedImmune) Recent Developments
    11.6 Roche
        11.6.1 Roche Corporation Information
        11.6.2 Roche Overview
        11.6.3 Roche OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Roche OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Roche Recent Developments
    11.7 Agenus
        11.7.1 Agenus Corporation Information
        11.7.2 Agenus Overview
        11.7.3 Agenus OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Agenus OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Agenus Recent Developments
    11.8 Bristol Myers Squibb
        11.8.1 Bristol Myers Squibb Corporation Information
        11.8.2 Bristol Myers Squibb Overview
        11.8.3 Bristol Myers Squibb OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bristol Myers Squibb OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bristol Myers Squibb Recent Developments
    11.9 Bioinvent
        11.9.1 Bioinvent Corporation Information
        11.9.2 Bioinvent Overview
        11.9.3 Bioinvent OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Bioinvent OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Bioinvent Recent Developments
    11.10 Sorrento Therapeutics
        11.10.1 Sorrento Therapeutics Corporation Information
        11.10.2 Sorrento Therapeutics Overview
        11.10.3 Sorrento Therapeutics OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Sorrento Therapeutics OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Sorrento Therapeutics Recent Developments
    11.11 Incyte
        11.11.1 Incyte Corporation Information
        11.11.2 Incyte Overview
        11.11.3 Incyte OX40 Receptor Agonist Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Incyte OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Incyte Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 OX40 Receptor Agonist Industry Chain Analysis
    12.2 OX40 Receptor Agonist Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 OX40 Receptor Agonist Production Mode & Process
    12.4 OX40 Receptor Agonist Sales and Marketing
        12.4.1 OX40 Receptor Agonist Sales Channels
        12.4.2 OX40 Receptor Agonist Distributors
    12.5 OX40 Receptor Agonist Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 OX40 Receptor Agonist Industry Trends
    13.2 OX40 Receptor Agonist Market Drivers
    13.3 OX40 Receptor Agonist Market Challenges
    13.4 OX40 Receptor Agonist Market Restraints
14 Key Findings in The Global OX40 Receptor Agonist Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global OX40 Receptor Agonist Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Fully Human IgG2 Agonist Ab
    Table 3. Major Manufacturers of Humanised IgG1 Agonist mAb
    Table 4. Major Manufacturers of Fully Human IgG1 Agonist mAb
    Table 5. Global OX40 Receptor Agonist Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global OX40 Receptor Agonist Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global OX40 Receptor Agonist Sales by Region (2017-2022) & (K Units)
    Table 8. Global OX40 Receptor Agonist Sales Market Share by Region (2017-2022)
    Table 9. Global OX40 Receptor Agonist Sales by Region (2023-2028) & (K Units)
    Table 10. Global OX40 Receptor Agonist Sales Market Share by Region (2023-2028)
    Table 11. Global OX40 Receptor Agonist Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global OX40 Receptor Agonist Revenue Market Share by Region (2017-2022)
    Table 13. Global OX40 Receptor Agonist Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global OX40 Receptor Agonist Revenue Market Share by Region (2023-2028)
    Table 15. Global OX40 Receptor Agonist Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global OX40 Receptor Agonist Sales Share by Manufacturers (2017-2022)
    Table 17. Global OX40 Receptor Agonist Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global OX40 Receptor Agonist Revenue Share by Manufacturers (2017-2022)
    Table 19. OX40 Receptor Agonist Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global OX40 Receptor Agonist Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global OX40 Receptor Agonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OX40 Receptor Agonist as of 2021)
    Table 22. OX40 Receptor Agonist Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers OX40 Receptor Agonist Product Offered
    Table 24. Date of Manufacturers Enter into OX40 Receptor Agonist Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global OX40 Receptor Agonist Sales by Type (2017-2022) & (K Units)
    Table 27. Global OX40 Receptor Agonist Sales by Type (2023-2028) & (K Units)
    Table 28. Global OX40 Receptor Agonist Sales Share by Type (2017-2022)
    Table 29. Global OX40 Receptor Agonist Sales Share by Type (2023-2028)
    Table 30. Global OX40 Receptor Agonist Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global OX40 Receptor Agonist Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global OX40 Receptor Agonist Revenue Share by Type (2017-2022)
    Table 33. Global OX40 Receptor Agonist Revenue Share by Type (2023-2028)
    Table 34. OX40 Receptor Agonist Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global OX40 Receptor Agonist Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global OX40 Receptor Agonist Sales by Application (2017-2022) & (K Units)
    Table 37. Global OX40 Receptor Agonist Sales by Application (2023-2028) & (K Units)
    Table 38. Global OX40 Receptor Agonist Sales Share by Application (2017-2022)
    Table 39. Global OX40 Receptor Agonist Sales Share by Application (2023-2028)
    Table 40. Global OX40 Receptor Agonist Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global OX40 Receptor Agonist Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global OX40 Receptor Agonist Revenue Share by Application (2017-2022)
    Table 43. Global OX40 Receptor Agonist Revenue Share by Application (2023-2028)
    Table 44. OX40 Receptor Agonist Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global OX40 Receptor Agonist Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America OX40 Receptor Agonist Sales by Type (2017-2022) & (K Units)
    Table 47. North America OX40 Receptor Agonist Sales by Type (2023-2028) & (K Units)
    Table 48. North America OX40 Receptor Agonist Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America OX40 Receptor Agonist Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America OX40 Receptor Agonist Sales by Application (2017-2022) & (K Units)
    Table 51. North America OX40 Receptor Agonist Sales by Application (2023-2028) & (K Units)
    Table 52. North America OX40 Receptor Agonist Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America OX40 Receptor Agonist Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America OX40 Receptor Agonist Sales by Country (2017-2022) & (K Units)
    Table 55. North America OX40 Receptor Agonist Sales by Country (2023-2028) & (K Units)
    Table 56. North America OX40 Receptor Agonist Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America OX40 Receptor Agonist Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe OX40 Receptor Agonist Sales by Type (2017-2022) & (K Units)
    Table 59. Europe OX40 Receptor Agonist Sales by Type (2023-2028) & (K Units)
    Table 60. Europe OX40 Receptor Agonist Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe OX40 Receptor Agonist Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe OX40 Receptor Agonist Sales by Application (2017-2022) & (K Units)
    Table 63. Europe OX40 Receptor Agonist Sales by Application (2023-2028) & (K Units)
    Table 64. Europe OX40 Receptor Agonist Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe OX40 Receptor Agonist Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe OX40 Receptor Agonist Sales by Country (2017-2022) & (K Units)
    Table 67. Europe OX40 Receptor Agonist Sales by Country (2023-2028) & (K Units)
    Table 68. Europe OX40 Receptor Agonist Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe OX40 Receptor Agonist Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific OX40 Receptor Agonist Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific OX40 Receptor Agonist Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific OX40 Receptor Agonist Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific OX40 Receptor Agonist Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific OX40 Receptor Agonist Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific OX40 Receptor Agonist Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific OX40 Receptor Agonist Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific OX40 Receptor Agonist Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific OX40 Receptor Agonist Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific OX40 Receptor Agonist Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific OX40 Receptor Agonist Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific OX40 Receptor Agonist Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America OX40 Receptor Agonist Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America OX40 Receptor Agonist Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America OX40 Receptor Agonist Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America OX40 Receptor Agonist Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America OX40 Receptor Agonist Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America OX40 Receptor Agonist Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America OX40 Receptor Agonist Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America OX40 Receptor Agonist Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America OX40 Receptor Agonist Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America OX40 Receptor Agonist Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America OX40 Receptor Agonist Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America OX40 Receptor Agonist Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa OX40 Receptor Agonist Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa OX40 Receptor Agonist Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa OX40 Receptor Agonist Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa OX40 Receptor Agonist Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa OX40 Receptor Agonist Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa OX40 Receptor Agonist Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa OX40 Receptor Agonist Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa OX40 Receptor Agonist Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa OX40 Receptor Agonist Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa OX40 Receptor Agonist Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa OX40 Receptor Agonist Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa OX40 Receptor Agonist Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Merk Corporation Information
    Table 107. Merk Description and Major Businesses
    Table 108. Merk OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. Merk OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Merk Recent Developments
    Table 111. Pfizer Corporation Information
    Table 112. Pfizer Description and Major Businesses
    Table 113. Pfizer OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Pfizer OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Pfizer Recent Developments
    Table 116. GlaxoSmithKline Corporation Information
    Table 117. GlaxoSmithKline Description and Major Businesses
    Table 118. GlaxoSmithKline OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. GlaxoSmithKline OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. GlaxoSmithKline Recent Developments
    Table 121. Glenmark Corporation Information
    Table 122. Glenmark Description and Major Businesses
    Table 123. Glenmark OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Glenmark OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Glenmark Recent Developments
    Table 126. AstraZeneca (MedImmune) Corporation Information
    Table 127. AstraZeneca (MedImmune) Description and Major Businesses
    Table 128. AstraZeneca (MedImmune) OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. AstraZeneca (MedImmune) OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. AstraZeneca (MedImmune) Recent Developments
    Table 131. Roche Corporation Information
    Table 132. Roche Description and Major Businesses
    Table 133. Roche OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. Roche OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Roche Recent Developments
    Table 136. Agenus Corporation Information
    Table 137. Agenus Description and Major Businesses
    Table 138. Agenus OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. Agenus OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Agenus Recent Developments
    Table 141. Bristol Myers Squibb Corporation Information
    Table 142. Bristol Myers Squibb Description and Major Businesses
    Table 143. Bristol Myers Squibb OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 144. Bristol Myers Squibb OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Bristol Myers Squibb Recent Developments
    Table 146. Bioinvent Corporation Information
    Table 147. Bioinvent Description and Major Businesses
    Table 148. Bioinvent OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 149. Bioinvent OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Bioinvent Recent Developments
    Table 151. Sorrento Therapeutics Corporation Information
    Table 152. Sorrento Therapeutics Description and Major Businesses
    Table 153. Sorrento Therapeutics OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 154. Sorrento Therapeutics OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Sorrento Therapeutics Recent Developments
    Table 156. Incyte Corporation Information
    Table 157. Incyte Description and Major Businesses
    Table 158. Incyte OX40 Receptor Agonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 159. Incyte OX40 Receptor Agonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Incyte Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. OX40 Receptor Agonist Distributors List
    Table 164. OX40 Receptor Agonist Customers List
    Table 165. OX40 Receptor Agonist Market Trends
    Table 166. OX40 Receptor Agonist Market Drivers
    Table 167. OX40 Receptor Agonist Market Challenges
    Table 168. OX40 Receptor Agonist Market Restraints
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. OX40 Receptor Agonist Product Picture
    Figure 3. Global OX40 Receptor Agonist Market Share by Type in 2021 & 2028
    Figure 3. Fully Human IgG2 Agonist Ab Product Picture
    Figure 4. Humanised IgG1 Agonist mAb Product Picture
    Figure 5. Fully Human IgG1 Agonist mAb Product Picture
    Figure 6. Global OX40 Receptor Agonist Market Share by Application in 2021 & 2028
    Figure 7. Cancers
    Figure 8. Myasthenia Gravis
    Figure 9. Psoriasis
    Figure 10. OX40 Receptor Agonist Report Years Considered
    Figure 11. Global OX40 Receptor Agonist Sales 2017-2028 (K Units)
    Figure 12. Global OX40 Receptor Agonist Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global OX40 Receptor Agonist Revenue 2017-2028 (US$ Million)
    Figure 14. Global OX40 Receptor Agonist Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global OX40 Receptor Agonist Sales Market Share by Region (2017-2022)
    Figure 16. Global OX40 Receptor Agonist Sales Market Share by Region (2023-2028)
    Figure 17. North America OX40 Receptor Agonist Sales YoY (2017-2028) & (K Units)
    Figure 18. North America OX40 Receptor Agonist Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe OX40 Receptor Agonist Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe OX40 Receptor Agonist Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific OX40 Receptor Agonist Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific OX40 Receptor Agonist Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America OX40 Receptor Agonist Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America OX40 Receptor Agonist Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa OX40 Receptor Agonist Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa OX40 Receptor Agonist Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The OX40 Receptor Agonist Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of OX40 Receptor Agonist in the World: Market Share by OX40 Receptor Agonist Revenue in 2021
    Figure 29. Global OX40 Receptor Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global OX40 Receptor Agonist Sales Market Share by Type (2017-2028)
    Figure 31. Global OX40 Receptor Agonist Revenue Market Share by Type (2017-2028)
    Figure 32. Global OX40 Receptor Agonist Sales Market Share by Application (2017-2028)
    Figure 33. Global OX40 Receptor Agonist Revenue Market Share by Application (2017-2028)
    Figure 34. North America OX40 Receptor Agonist Sales Market Share by Type (2017-2028)
    Figure 35. North America OX40 Receptor Agonist Revenue Market Share by Type (2017-2028)
    Figure 36. North America OX40 Receptor Agonist Sales Market Share by Application (2017-2028)
    Figure 37. North America OX40 Receptor Agonist Revenue Market Share by Application (2017-2028)
    Figure 38. North America OX40 Receptor Agonist Sales Share by Country (2017-2028)
    Figure 39. North America OX40 Receptor Agonist Revenue Share by Country (2017-2028)
    Figure 40. U.S. OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe OX40 Receptor Agonist Sales Market Share by Type (2017-2028)
    Figure 43. Europe OX40 Receptor Agonist Revenue Market Share by Type (2017-2028)
    Figure 44. Europe OX40 Receptor Agonist Sales Market Share by Application (2017-2028)
    Figure 45. Europe OX40 Receptor Agonist Revenue Market Share by Application (2017-2028)
    Figure 46. Europe OX40 Receptor Agonist Sales Share by Country (2017-2028)
    Figure 47. Europe OX40 Receptor Agonist Revenue Share by Country (2017-2028)
    Figure 48. Germany OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 49. France OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific OX40 Receptor Agonist Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific OX40 Receptor Agonist Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific OX40 Receptor Agonist Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific OX40 Receptor Agonist Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific OX40 Receptor Agonist Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific OX40 Receptor Agonist Revenue Share by Region (2017-2028)
    Figure 59. China OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 62. India OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America OX40 Receptor Agonist Sales Market Share by Type (2017-2028)
    Figure 70. Latin America OX40 Receptor Agonist Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America OX40 Receptor Agonist Sales Market Share by Application (2017-2028)
    Figure 72. Latin America OX40 Receptor Agonist Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America OX40 Receptor Agonist Sales Share by Country (2017-2028)
    Figure 74. Latin America OX40 Receptor Agonist Revenue Share by Country (2017-2028)
    Figure 75. Mexico OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa OX40 Receptor Agonist Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa OX40 Receptor Agonist Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa OX40 Receptor Agonist Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa OX40 Receptor Agonist Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa OX40 Receptor Agonist Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa OX40 Receptor Agonist Revenue Share by Country (2017-2028)
    Figure 84. Turkey OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE OX40 Receptor Agonist Revenue (2017-2028) & (US$ Million)
    Figure 87. OX40 Receptor Agonist Value Chain
    Figure 88. OX40 Receptor Agonist Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed